Spectrum Pharmaceuticals Stock News

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) with the stream of -4.02% also noticed, India Regions Financial Corporation (NYSE:RF) encountered a rapid change of -0.41% in the last hour of Friday’s trading session. … The post Sizzling Stock Alert: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Regions Financial Corporation (NYSE:RF) appeared first on Stocks Equity .

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update

Pacira's (PCRX) flagship product, Exparel, has been performing well since its launch. The company's efforts to expand the drug's label also holds promise.

Spectrum Pharmaceuticals Inc (NASDAQ: SPPI ) announced the presentation of safety and efficacy results from Cohort 4 of the ZENITH20 trial evaluating poziotinib in various non-small cell lung cancer settings. The data comes from 70 first-line patients with non-small lung cancer (NSCLC) with HER2 exon 20 insertion mutations who received 16 … Full story available on Benzinga.com

Pacira's (PCRX) earnings surpass estimates in the fourth quarter of 2021 while revenues are slightly above estimates.

3 Penny Stocks to Watch Under $1 The post Best Penny Stocks To Buy Now? 3 Reddit Stocks To Watch Under $1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks to Watch Under $1 The post Best Penny Stocks To Buy Now? 3 Reddit Stocks To Watch Under $1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

The U.S. Food and Drug Administration ((FDA)) accepted for review Spectrum Pharmaceuticals'' (SPPI) new drug application ((NDA)) for poziotinib to treat patients with locally advanced…

Mumbai: Aurobindo Pharma is understood to have shortlisted four bulge-bracket global investors - Blackstone Group, Advent International, CVC Capital and Baring Private Equity Asia - for a potential billion-dollar investment in its injectables business unit in lieu of a 20-30% stake.The transaction is seen as a prelude to Aurobindo''s potential value-unlocking exercise, which would eventually involve listing the injectables business separately, multiple industry sources with knowledge of the matter told ET."We are in advanced negotiations with PE funds for the stake sale. We hope to receive binding offers soon and are aiming to sign a definitive agreement by the fiscal end," said one of the sources cited above. Kotak Mahindra Capital is running a formal process for the drugmaker to find a buyer. 89441599Several other funds, including TPG Capital Management, Bain Capital, Carlyle Group and PAG, were also in the consideration set.Last month, ET first reported that Aurobindo plans to sell a minority stake in the injectables business and has initiated talks with PE funds.Mail sent to Aurobindo, Blackstone, CVC, and Kotak Mahindra Capital remained unanswered.

Are these on your list of penny stocks to watch right now? The post 3 Top Penny Stocks To Buy For Under $5 Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Are these on your list of penny stocks to watch right now? The post 3 Top Penny Stocks To Buy For Under $5 Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

The heavy selling pressure might have exhausted for Spectrum Pharma (SPPI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street ana

The heavy selling pressure might have exhausted for Spectrum Pharma (SPPI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street ana

Check out these penny stocks insiders are buying Losers ION Geophysical Corporation (NYSE: IO ) shares fell 53.6% to settle at $0.51 on Thursday. Epizyme, Inc. (NASDAQ: EPZM ) shares dipped 44.2% to close at $1.06 on Thursday after the company priced an underwritten public offering of 56,666,667 shares at $1.50 per share, before underwriting discounts. TG Therapeutics, Inc. (NASDAQ: TGTX ) dropped 40.5% to settle at $8.27 on Thursday. TG Therapeutics said the FDA imposed partial clinical hold on select studies of U2 and its components for CLL and NHL. Cyngn Inc. (NASDAQ: CYN ) tumbled 35.7% to close at $1.62. PetVivo Holdings, Inc. (NASDAQ: PETV ) fell 35% to close at $1.30. PetVivo recently announced distribution of its veterinary medical device, SPRYNG, by Vetcove, Inc. Advanced Human Imaging Limited (NASDAQ: AHI ) fell 33.8% to settle at $1.82. Advanced Human Imaging recently signed partnership with Activate Health OÜ. Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI ) dropped 33.6% to close at $0.6280.

Gap Inc. is leaving the S&P 500 index , index provider S&P Dow Jones Indices said late Wednesday, underscoring the challenges faced by retailers in recent years. Constellation Energy Corp. will replace Gap in the key equity index, with the retailer replacing fast-food chain Jack in the Box Inc. in the S&P MidCap 400. Jack in the Box will replace Spectrum Pharmaceuticals Inc. in the S&P SmallCap 600, S&P Dow Jones said. The changes take effect on Feb. 3. Exelon Corp. is spinning off Constellation Energy in a transaction expected to close Feb. 2. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.